Âé¶ą´«Ă˝É«ÇéƬ

News

UTSW researchers discover how food-poisoning bacteria infect the intestines

Findings revealing efficient assembly of virulence machine could lead to development of treatments for diseases caused by gut pathogens
University of Texas Southwestern Medical Center
By University of Texas Southwestern Medical Center
June 3, 2023

Researchers at the University of Texas Southwestern Medical Center have discovered how a bacterium that infects people after they eat raw or undercooked shellfish creates syringe-like structures to inject its toxins into intestinal cells. The findings, published in , could lead to new ways to treat food poisoning caused by Vibrio parahaemolyticus.

Kim Orth, Ph.D., is a Howard Hughes Medical Institute Investigator, a member of the National Academy of Sciences, and a W.W. Caruth, Jr. Scholar in Biomedical Research, and holds the Earl A. Forsythe Chair in Biomedical Science.
Kim Orth is a Howard Hughes Medical Institute investigator.

“We have provided the first visual evidence of how a gut bacterial pathogen uses this assembly method to build a syringe to deliver a lethal injection to intestinal cells,” said  a professor of molecular biology and biochemistry and a Howard Hughes Medical Institute investigator at UTSW. “This work provides a new view of how enteric bacteria when exposed to bile acids efficiently respond and build a virulence system.”

This is a figure from the paper “Membrane-localized expression, production and assembly of Vibrio parahaemolyticus T3SS2 provides evidence for transertion.” It shows a two-step transertion model for the localized membrane assembly of the T3SS2 apparatus in V. parahaemolyticus.
This is a figure from the paper “.” It shows a two-step transertion model for the localized membrane assembly of the T3SS2 apparatus in V. parahaemolyticus.

V. parahaemolyticus, commonly found in warm coastal waters, is a leading cause of seafood-related food poisoning. People infected often have diarrhea, cramping, vomiting, fever and chills.

Researchers knew that V. parahaemolyticus injects molecules into human cells using a structure called the type III secretion system 2 (T3SS2). However, these syringes, composed of 19 different proteins, are not produced or assembled until the bacteria are inside the intestines. Scientists were not sure exactly how this occurs.

The latest findings build on the work of a by the .  Orth and her colleagues tagged components of the V. parahaemolyticus T3SS2 with fluorescent markers and used super-resolution microscopy to track their locations as the bacteria were grown in different conditions. The researchers discovered that when V. parahaemolyticus is exposed to bile acids — digestive molecules in the intestines — the bacteria move DNA containing the T3SS2 genes close to their membrane.

Then, at the exact site where the T3SS2 is needed, V. parahaemolyticus transcribes that DNA into RNA, translates the RNA into protein, and assembles the components of the T3SS2 through the membrane in a process known as transertion. “It is like watching the assembly of a factory that produces a large molecular machine within an hour,” Orth said. 

Karan Kaval, Ph.D., a UTSW research specialist and member of the Orth lab, was first author of the study.
Karan Kaval, a UTSW research specialist and member of the Orth lab, was first author of the study.

These steps were previously thought to occur in more disparate locations around a cell, but pulling the machinery together into one place on the bacterium’s membrane likely helps V. parahaemolyticus more quickly and efficiently build the T3SS2 and infect cells. Since other disease-causing gut bacteria contain molecular components similar to V. parahaemolyticus, the phenomenon of transertion may be widely used, the researchers hypothesize.

“Our findings imply that other gastrointestinal pathogens may also use this mechanism to mediate efficient assembly of complex molecular machines in response to environmental cues,” said UTSW research specialist , first author of the paper.

More work is needed to know which bacteria use transertion to build their T3SS structures and whether drugs could be developed that block transertion to treat V. parahaemolyticus infections.

UTSW researcher  also contributed to this study.

This article was first published by the University of Texas Southwestern Medical Center.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center

The University of Texas Southwestern Medical Center integrates pioneering biomedical research with exceptional clinical care and education. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research to new clinical treatments.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.